Artelo Biosciences, Inc.
ARTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621221
No open-market purchases or sales by Artelo Biosciences, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $132.0K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Artelo Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 15 | 20 | +5 |
| Shares | 1.33M | 2.77M | +1.44M (+108.4%) |
| Value | $2.17M | $3.29M | +$1.12M (+51.8%) |
New holders (6)
Institutions that held Artelo Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 556,738 | $663.0K | 0.00% |
| Two Sigma Advisers, LP | 260,000 | $309.0K | 0.00% |
| Two Sigma Investments, LP | 163,891 | $195.0K | 0.00% |
| HighTower Advisors, LLC | 62,000 | $74.0K | 0.00% |
| Penserra Capital Management LLC | 28,427 | $27.0K | 0.00% |
| FMR LLC | 68 | $0 | 0.00% |
Sold out (1)
Institutions that held Artelo Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Jane Street Group, LLC | 21,108 | $34.0K |